An overview of marketed combined oral contraceptives approved by FDA from 2007 to 2011

In: Chinese Journal of New Drugs and Clinical Remedies · 2012 · W2385666569
article OA: closed CC0
View on OpenAlex

Abstract

This paper focused on the review of marketed combined oral contraceptives approved by FDA from 2007 to 2011,including progestin such as norethisterone,levonorgestrel,drospirenone,norgestimate, desogestrel and dienogest combined with estrogen.Moreover,the paper explained the pharmacology characteristic,pharmacokinetics,and the development of oral preparation of these progestins in order to point out the development tendency and application prospect of the combined oral contraceptives.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-10T10:10:23.089715+00:00
License: CC0 · commercial use OK